Changjiang Huang

Tianjin Institute of Pharmaceutical Research - Tianjin Key Laboratory of Molecular Design and Drug Discovery

Tianjin

China

  • Tianjin Institute of Pharmaceutical Research - Tianjin Key Laboratory of Molecular Design and Drug Discovery

SCHOLARLY PAPERS

1

DOWNLOADS

36

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Indirubin-3’-Monoxime Acts as a Novel Proteasome Inhibitor: Therapeutic Application in Multiple Myeloma

Number of pages: 37 Posted: 18 Oct 2021
Zhen Yu, Lanting Liu, Kefei Wang, Hao Sun, Xiaojing We, Weiwei Sui, Teng Fang, Lu Wang, Ying Li, Yaozhong Zhao, Yi He, Wenyang Huang, Gang An, Fancui Meng, Changjiang Huang, Tengteng Yu, Kenneth. C. Anderson, Tao Cheng, Lugui Qiu and Mu Hao
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Tianjin Institute of Pharmaceutical Research - Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research - Tianjin Key Laboratory of Molecular Design and Drug Discovery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Harvard University - Jerome Lipper Center for Multiple Myeloma Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology
Downloads 36 (981,105)

Abstract:

Loading...

Multiple myeloma, Proteasome inhibitors, Drug resistance, PSME3 (PA28γ), PSME4 (PA200), Indirubin-3'-monoxime